Literature DB >> 18165704

Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids.

Xi Chen1, Wujuan Zhang, James Laird, Stanley L Hazen, Robert G Salomon.   

Abstract

Low density lipoprotein contains traces of biologically active platelet-activating factor (PAF)-like ether phosphatidylcholines (PCs). These oxidatively truncated alkylacylphosphatidylcholines (OxPAFs) are presumably formed through the oxidative truncation of 1-alkyl-2-polyunsaturated fatty acyl PCs. We now report that a diverse structural variety of OxPAFs are generated in small unilamellar vesicles (SUVs) upon myeloperoxidase (MPO)-promoted autoxidation of ether PCs that incorporate linoleoyl, arachidonyl, or docosahexaenoyl groups at the sn-2 position. Total syntheses are reported that confirm the identities of the new OxPAFs and will facilitate the evaluation of their biologically important chemistry and activities. Especially noteworthy is the formation of OxPAFs containing gamma-hydroxyalkenal functionality. Analogous oxidatively truncated diacylphosphatidylcholines are biologically important because they and their more oxidized derivatives are strong ligands for the scavenger receptor CD36. Furthermore, their covalent adduction with proteins can interfere with protein function or generate biologically active carboxyalkylpyrrole derivatives. We now find a profound influence of membrane composition on the stability of OxPAFs. In the presence of a polyunsaturated diacyl PC, the linoleic acid ester of 2-lysophosphatidylcholine, MPO induces the oxidation of aldehydes to carboxylic acids and the further oxidative truncation of gamma-hydroxyalkenals. Remarkably, these reactions do not occur readily with MPO in SUVs composed entirely of saturated diacyl-PCs. A mechanistic rationale is presented that can account for this dichotomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165704      PMCID: PMC2836539          DOI: 10.1194/jlr.M700598-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

1.  Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

Authors:  John W Crabb; Masaru Miyagi; Xiaorong Gu; Karen Shadrach; Karen A West; Hirokazu Sakaguchi; Motohiro Kamei; Azeem Hasan; Lin Yan; Mary E Rayborn; Robert G Salomon; Joe G Hollyfield
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

2.  Lipid rafts--composition, characterization, and controversies.

Authors:  Philip C Calder; Parveen Yaqoob
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

3.  Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease.

Authors:  R Schmidt; U Meier; P Markart; F Grimminger; H G Velcovsky; H Morr; W Seeger; A Günther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11       Impact factor: 5.464

4.  Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.

Authors:  Henry F Hoff; June O'Neil; Zhiping Wu; George Hoppe; Robert L Salomon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

5.  Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1).

Authors:  Mingjiang Sun; Yijun Deng; Eugenia Batyreva; Wei Sha; Robert G Salomon
Journal:  J Org Chem       Date:  2002-05-31       Impact factor: 4.354

6.  Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and Peptide adduction chemistry.

Authors:  Xiaorong Gu; Mingjiang Sun; Bogdan Gugiu; Stanley Hazen; John W Crabb; Robert G Salomon
Journal:  J Org Chem       Date:  2003-05-16       Impact factor: 4.354

7.  A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Maria Febbraio; David P Hajjar; Roy L Silverstein; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

8.  Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.

Authors:  Ganesamoorthy Subbanagounder; Yujin Deng; Christine Borromeo; Alek N Dooley; Judith A Berliner; Robert G Salomon
Journal:  Vascul Pharmacol       Date:  2002-04       Impact factor: 5.773

9.  Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration.

Authors:  Xiaorong Gu; Susan Gillette Meer; Masaru Miyagi; Mary E Rayborn; Joe G Hollyfield; John W Crabb; Robert G Salomon
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

10.  Gamma-hydroxyalkenals are oxidatively cleaved through Michael addition of acylperoxy radicals and fragmentation of intermediate beta-hydroxyperesters.

Authors:  Yuvaraju N Balamraju; Mingjiang Sun; Robert G Salomon
Journal:  J Am Chem Soc       Date:  2004-09-22       Impact factor: 15.419

View more
  13 in total

1.  Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids.

Authors:  Jaewoo Choi; Wujuan Zhang; Xiaodong Gu; Xi Chen; Li Hong; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2010-10-25       Impact factor: 3.739

2.  Tyrosine-lipid peroxide adducts from radical termination: para coupling and intramolecular Diels-Alder cyclization.

Authors:  Roman Shchepin; Matias N Möller; Hye-young H Kim; Duane M Hatch; Silvina Bartesaghi; Balaraman Kalyanaraman; Rafael Radi; Ned A Porter
Journal:  J Am Chem Soc       Date:  2010-11-19       Impact factor: 15.419

Review 3.  Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.

Authors:  Thomas M McIntyre
Journal:  Biochim Biophys Acta       Date:  2012-03-16

4.  An (1)O2 route to γ-hydroxyalkenal phospholipids by vitamin E-induced fragmentation of hydroperoxydiene-derived endoperoxides.

Authors:  Xiaodong Gu; Wujuan Zhang; Jaewoo Choi; Wei Li; Xi Chen; James M Laird; Robert G Salomon
Journal:  Chem Res Toxicol       Date:  2011-05-31       Impact factor: 3.739

5.  Lipid profiling of the Arabidopsis hypersensitive response reveals specific lipid peroxidation and fragmentation processes: biogenesis of pimelic and azelaic acid.

Authors:  Maria Zoeller; Nadja Stingl; Markus Krischke; Agnes Fekete; Frank Waller; Susanne Berger; Martin J Mueller
Journal:  Plant Physiol       Date:  2012-07-22       Impact factor: 8.340

Review 6.  Critical insights into cardiovascular disease from basic research on the oxidation of phospholipids: the γ-hydroxyalkenal phospholipid hypothesis.

Authors:  Robert G Salomon; Xiaodong Gu
Journal:  Chem Res Toxicol       Date:  2011-09-30       Impact factor: 3.739

7.  Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.

Authors:  Ravi P Sahu; Amal A Kozman; Yongxue Yao; Sonia C DaSilva; Samin Rezania; Kellie C Martel; Simon J Warren; Jeffrey B Travers; Raymond L Konger
Journal:  Carcinogenesis       Date:  2012-01-04       Impact factor: 4.944

Review 8.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

Authors:  Omid Veiseh; Jonathan W Gunn; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

9.  Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL.

Authors:  Rui Chen; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

10.  Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor.

Authors:  Rui Chen; Xi Chen; Robert G Salomon; Thomas M McIntyre
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-26       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.